chr16-75479230-A-C
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_021615.5(CHST6):āc.599T>Gā(p.Leu200Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000306 in 1,611,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Consequence
NM_021615.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHST6 | NM_021615.5 | c.599T>G | p.Leu200Arg | missense_variant | 3/3 | ENST00000332272.9 | |
CHST6 | NR_163480.1 | n.733+2587T>G | intron_variant, non_coding_transcript_variant | ||||
CHST6 | NR_163481.1 | n.577+2587T>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHST6 | ENST00000332272.9 | c.599T>G | p.Leu200Arg | missense_variant | 3/3 | 3 | NM_021615.5 | P1 | |
ENST00000530512.3 | n.425+2910A>C | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000225 AC: 55AN: 244732Hom.: 0 AF XY: 0.000225 AC XY: 30AN XY: 133274
GnomAD4 exome AF: 0.000316 AC: 461AN: 1459028Hom.: 0 Cov.: 31 AF XY: 0.000314 AC XY: 228AN XY: 725996
GnomAD4 genome AF: 0.000210 AC: 32AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74366
ClinVar
Submissions by phenotype
Macular corneal dystrophy Pathogenic:7
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 09, 2019 | The CHST6 c.599T>G (p.Leu200Arg) missense variant has been reported in at least seven studies in which it is identified in a total of 37 individuals with macular corneal dystrophy (MCD) type I or II from 31 families, including in seven in a homozygous state (two of whom are related); 19 in a compound heterozygous state (two of whom are related); and 11 in a heterozygous state (two of whom are related) (El-Ashry et al. 2002; Aldave et al. 2004; Klintworth et al. 2006; Gruenauer-Kloevekorn et al. 2008; Liskova et al. 2008; Dudakova et al. 2014; Nowinska et al. 2014). The p.Leu200Arg variant was detected in a heterozygous state in one of 694 control chromosomes and is reported at a frequency of 0.000471 in the European (non-Finnish) population of the Genome Aggregation Database. The Leu200 residue is noted to be highly conserved. Based on the collective evidence, the p.Leu200Arg variant is classified as pathogenic for macular corneal dystrophy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Oct 13, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | May 09, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2004 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 28, 2016 | The p.Leu200Arg variant in CHST6 has been reported in at least 17 individuals wi th macular corneal dystrophy who also tested positive for a reduction in keratin sulfate consistent with CHST6 deficiency (14 compound heterozygotes, 1 homozygo te and 2 heterozygotes) (El-Ashry 2002, El-Ashry 2005, Abbruzzese 2004, Klintwor th 2006, Liskova 2008). This variant has been identified in 0.03% (30/115,942) o f chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstit ute.org; dbSNP rs28937879). Although it has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency . In summary, this variant meets our criteria to be classified as pathogenic for macular corneal dystrophy in an autosomal recessive manner based upon its biall elic occurrence in affected individuals and functional evidence. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 24, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Nov 16, 2021 | This sequence change replaces leucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 200 of the CHST6 protein (p.Leu200Arg). This variant is present in population databases (rs28937879, gnomAD 0.05%). This missense change has been observed in individuals with macular corneal dystrophy (PMID: 11818380, 16568029, 32472422). It has also been observed to segregate with disease in related individuals. This variant is also known as 1291T>G. ClinVar contains an entry for this variant (Variation ID: 5075). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. - |
Macular corneal dystrophy, type II Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2004 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at